Tetrakis(2-methoxyisobutylisocyanide)copper(I) tetrafluoroborate Active Not Recruiting Phase 0 Trials for Estrogen Receptor Negative / Triple Negative Breast Carcinoma / HER2/Neu Negative / Progesterone Receptor Negative Diagnostic

Indications	Status	Purpose	Phase
DBCOND0036417 (Estrogen Receptor Negative) DBCOND0129280 (Triple Negative Breast Carcinoma) DBCOND0034239 (HER2/Neu Negative) DBCOND0038639 (Progesterone Receptor Negative)	Active Not Recruiting	Diagnostic	0

clinicaltrials.gov Identifier	Title	Drugs
NCT02744053	DCE-MRI and MBI in Assessing Tumor Response to Chemotherapy in Patients With Triple Negative Breast Cancer	Technetium Tc-99m sestamibi (DB09161) Tetrakis(2-methoxyisobutylisocyanide)copper(I) tetrafluoroborate (DB14106)